LADENBURG THALMANN FINANCIAL SERVICES INC. - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 56 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q4 2019$3,0000.0%1,100
+10.0%
0.00%
Q3 2019$3,000
-25.0%
1,000
-33.3%
0.00%
Q2 2019$4,000
-33.3%
1,5000.0%0.00%
Q1 2019$6,000
+20.0%
1,5000.0%0.00%
Q4 2018$5,000
-44.4%
1,5000.0%0.00%
Q3 2018$9,000
+80.0%
1,500
+50.0%
0.00%
Q2 2018$5,0000.0%1,0000.0%0.00%
Q1 2018$5,000
-16.7%
1,0000.0%0.00%
Q4 2017$6,000
-95.1%
1,000
-95.5%
0.00%
-100.0%
Q3 2017$122,000
+14.0%
22,000
-4.3%
0.00%0.0%
Q2 2017$107,000
+2040.0%
23,000
+2200.0%
0.00%
Q1 2017$5,000
-54.5%
1,0000.0%0.00%
Q4 2016$11,000
+22.2%
1,0000.0%0.00%
Q3 2016$9,000
+50.0%
1,0000.0%0.00%
Q2 2016$6,000
-14.3%
1,0000.0%0.00%
Q1 2016$7,000
-12.5%
1,0000.0%0.00%
Q4 2015$8,000
-27.3%
1,000
-33.3%
0.00%
Q3 2015$11,000
+37.5%
1,500
+100.0%
0.00%
Q2 2015$8,000
+60.0%
750
+50.0%
0.00%
Q1 2015$5,000
+25.0%
5000.0%0.00%
Q4 2014$4,0005000.00%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q2 2016
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,000,000$7,330,0003.56%
Sio Capital Management, LLC 336,286$2,465,0001.69%
Opaleye Management Inc. 285,000$2,089,0001.03%
SENZAR ASSET MANAGEMENT, LLC 864,408$6,336,111,0000.92%
MENORA MIVTACHIM HOLDINGS LTD. 1,350,847$9,902,0000.74%
Ghost Tree Capital, LLC 150,000$1,100,0000.50%
PURA VIDA INVESTMENTS, LLC 102,000$748,0000.43%
SPHERA FUNDS MANAGEMENT LTD. 380,000$2,785,0000.36%
J. Goldman & Co LP 474,810$3,480,0000.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 948,934$6,956,0000.27%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders